News
GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...
The percentage of overweight or obese adults prescribed GLP-1s jumped by almost 587% between 2019 and 2024, according to a ...
Blue Cross plans are retreating from GLP-1 weight-loss drug coverage after spending hundreds of millions of dollars on the ...
10d
News Medical on MSNGLP-1 RA medications safe and effective for treating obesity in adults with mental illness: StudyGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in ...
You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...
Discover how Ozempic is transforming America's eating, shopping, and dressing habits, with insights from Dr. Alexandra Sowa's ...
Researchers are working to make GLP-1 medications like Ozempic and Wegovy available to consumers as pills, instead of being ...
GLP-1 weight-loss drugs are reshaping dairy demand by curbing cravings for processed, fatty, and sugary products, fueling a ...
13d
HealthDay on MSNGLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, DepressionFor patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not ...
Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...
13d
MedPage Today on MSNGLP-1 Leads to Similar Cognitive Outcomes as Other Diabetes Drugs, Trial Data ShowCognitive performance was not different among four classes of glucose-lowering medications for type 2 diabetes, data from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results